That slump has driven its dividend yield up to more than 5%. While Kenvue stock is down this year, it could soar in 2026.

Johnson & Johnson (NYSE:JNJ) is one of Ray Dalio’s latest top stock positions. On October 7, a Los Angeles jury ordered ...

The multibillion-dollar corporation is still grappling with lawsuits from more than 62,000 claimants in the US alleging its ...

Breaking up isn’t so hard to do, after all. Just two years after spinning off its consumer products as Kenvue Inc., Johnson & ...

The sale of baby powder containing talc stopped in the UK in 2023. The UK action mirrors extensive litigation in the US, ...

Thousands in the UK sue Johnson & Johnson over asbestos-linked talc. The £1 billion lawsuit could award victims up to ...

When Johnson & Johnson announced its switch from talcum powder to a corn starch–based formula for its baby products, it ...

J&J in 2023 announced a two-year restructuring program for its orthopedics business, saying it planned to exit certain ...

Johnson & Johnson is narrowing its focus again, nearly four years after peeling off its consumer health business. The health care giant said Tuesday that it will separate its orthopedics business ...

Johnson & Johnson said on Tuesday it plans to separate its orthopedics business into a standalone company within the next 18 ...

Tuco Kids bets on natural ingredients to market its skincare and haircare products aimed at the underserved section between ...